Zhang H - Search Results

1

Monitoring serum HER2 levels in breast cancer patients.

Tchou J, Lam L, Li YR, Edwards C, Ky B, Zhang H. Tchou J, et al. Among authors: zhang h. Springerplus. 2015 May 22;4:237. doi: 10.1186/s40064-015-1015-6. eCollection 2015. Springerplus. 2015. PMID: 26069876 Free PMC article.

2

Mesothelin, a novel immunotherapy target for triple negative breast cancer.

Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Tchou J, et al. Among authors: zhang pj, zhang h. Breast Cancer Res Treat. 2012 Jun;133(2):799-804. doi: 10.1007/s10549-012-2018-4. Epub 2012 Mar 15. Breast Cancer Res Treat. 2012. PMID: 22418702 Free PMC article.

3

Challenges in the clinical utility of the serum test for HER2 ECD.

Lam L, McAndrew N, Yee M, Fu T, Tchou JC, Zhang H. Lam L, et al. Among authors: zhang h. Biochim Biophys Acta. 2012 Aug;1826(1):199-208. doi: 10.1016/j.bbcan.2012.03.012. Epub 2012 Apr 3. Biochim Biophys Acta. 2012. PMID: 22521738 Free PMC article. Review.

4

scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.

Cai Z, Fu T, Nagai Y, Lam L, Yee M, Zhu Z, Zhang H. Cai Z, et al. Among authors: zhang h. Cancer Res. 2013 Apr 15;73(8):2619-27. doi: 10.1158/0008-5472.CAN-12-3920. Epub 2013 Feb 8. Cancer Res. 2013. PMID: 23396586 Free PMC article.

5

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.

Lam L, Czerniecki BJ, Fitzpatrick E, Xu S, Schuchter L, Xu X, Zhang H. Lam L, et al. Among authors: zhang h. J Mol Biomark Diagn. 2014 Nov 14;4(3):151. doi: 10.4172/2155-9929.1000151. J Mol Biomark Diagn. 2014. PMID: 25089226 Free PMC article.

6

A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γ.

Zhang H, Lam L, Nagai Y, Zhu Z, Chen X, Ji MQ, Greene MI. Zhang H, et al. Oncoimmunology. 2018 Feb 8;7(4):e1300739. doi: 10.1080/2162402X.2017.1300739. eCollection 2018. Oncoimmunology. 2018. PMID: 29632709 Free PMC article.

7

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.

Kodumudi KN, Ramamoorthi G, Snyder C, Basu A, Jia Y, Awshah S, Beyer AP, Wiener D, Lam L, Zhang H, Greene MI, Costa RLB, Czerniecki BJ. Kodumudi KN, et al. Among authors: zhang h. Front Immunol. 2019 Aug 14;10:1939. doi: 10.3389/fimmu.2019.01939. eCollection 2019. Front Immunol. 2019. PMID: 31475002 Free PMC article.

8

Rational Design of Constrained Peptides as Protein Interface Inhibitors.

Murali R, Zhang H, Cai Z, Lam L, Greene M. Murali R, et al. Among authors: zhang h. Antibodies (Basel). 2021 Aug 16;10(3):32. doi: 10.3390/antib10030032. Antibodies (Basel). 2021. PMID: 34449551 Free PMC article. Review.

9

HED, a Human-Engineered Domain, Confers a Unique Fc-Binding Activity to Produce a New Class of Humanized Antibody-like Molecules.

Zhu Z, Goel PN, Zheng C, Nagai Y, Lam L, Samanta A, Ji M, Zhang H, Greene MI. Zhu Z, et al. Among authors: zhang h. Int J Mol Sci. 2023 Mar 30;24(7):6477. doi: 10.3390/ijms24076477. Int J Mol Sci. 2023. PMID: 37047449 Free PMC article.

10

Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics.

Lengfeld J, Zhang H, Stoesz S, Murali R, Pass F, Greene MI, Goel PN, Grover P. Lengfeld J, et al. Among authors: zhang h. Breast Cancer (Dove Med Press). 2021 Oct 14;13:575-593. doi: 10.2147/BCTT.S331844. eCollection 2021. Breast Cancer (Dove Med Press). 2021. PMID: 34703307 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129,731 results

Search Page

Filters